-
Walmart proposes $3.1B opioid settlement
Walmart has reached a possible $3.1 billion opioid settlement with state and local governments, according to a Nov. 15 news release from the company. -
Fentanyl vaccine could stop opioid use disorder relapses
University of Houston researchers have developed a fentanyl vaccine that could prevent relapses for individuals with opioid use disorder. -
CDC updates clinical guidelines for prescribing opioids
The CDC has released updated and expanded recommendations on providing pain care for adults with short- and long-term pain, which replace 2016 guidelines. -
CVS Health, Walgreens each to settle all opioid cases for $5B
For $5 billion, CVS Health will settle all lawsuits — some that have lasted more than a decade — accusing the retail pharmacy chain of fueling the opioid epidemic. Walgreens also plans to settle its lawsuits for $4.95 billion over the next 15 years. -
Majority of physicians favor continuing telehealth for opioid use disorder, Yale study finds
Seventy-percent of physicians in a Yale survey said they would be likely to use telehealth to treat opioid use disorder patients after the COVID-19 pandemic. -
Dartmouth Health study offers treatment opportunities for opioid use disorder
Lebanon, N.H.-based Dartmouth Health's Addiction Treatment Program is participating in a five-year, nationwide study to test strategies to help new patients stay in treatment and stable patients to end treatment safely when ready. -
Colorado distributes $18M in opioid settlement funds
The Colorado Opioid Abatement Council paved the way for several local governments to receive more than $18 million in opioid settlement funds. -
RWJBarnabas institute awarded $3.75M for opioid recovery services
West Orange, N.J.-based RWJBarnabas' Institute for Prevention and Recovery has been gifted $3.75 million from the Substance Abuse and Mental Health Services Administration for opioid use disorder medication access. -
Spero Health opens 3 new outpatient addiction treatment clinics
Brentwood, Tenn.-based Spero Health opened three new outpatient addiction treatment clinics, according to a Sept. 26 news release. -
Oregon health officials sound alarm on increased overdose deaths
Health officials in Oregon are sounding the alarm regarding fentanyl overdoses and warning legislators that the state's drug epidemic is worsening, according to a Sept. 21 report from the Oregon Capital Chronicle. -
CVS, Walmart settle for $147M in West Virginia opioid case
Retail pharmacy chains CVS and Walmart have settled for $147.5 million in West Virginia lawsuits that accused the companies of oversupplying opioids, Patrick Morrisey, the state's attorney general, said in a Sept. 20 news conference. -
New York Health Department issues warning on increase in opioid-related deaths
The New York State Department of Health has reported an increase in opioid-related overdoses in the Central New York region, according to a Sept. 13 report from The Ithaca Voice. -
Kansas governor announces $3.2M to aid first responders combatting opioids
Kansas Gov. Laura Kelly announced $3.2 million in grants to assist rural first responders in combatting opioid abuse, according to an Aug. 23 statement from the governor's office. -
Reimbursement for cryoneurolysis with iovera° for OA knee pain
Using the correct current procedural terminology (CPT) codes is crucial for documenting — and getting reimbursement for — novel treatments for which there is specific but narrowly defined guidance. -
Cryoneurolysis with iovera° for osteoarthritis knee pain: clinical evidence and experience in pre-total knee arthroplasty and non-surgical patients
Effective pain management often relies on administering opioid-based medication, but as opioids have known side effects and can lead to misuse and abuse, alternative approaches that provide non-medicated pain relief and are more versatile hold promise for improving patient care. -
Tennessee files suit against Walgreens over opioid sales + 4 recent opioid stories
Tennessee Attorney General Herbert Slatery III is suing Walgreens and accusing the pharmacy chain of creating a public nuisance by illegally selling and distributing opioids, according to an Aug. 3 news release. -
Teva reaches $4.25B settlement in national opioid cases
Teva Pharmaceuticals, an Israel-based drug manufacturer, has agreed to settle more than 3,000 opioid cases up to $4.25 billion in all cash over the next 13 years, according to The New York Times and Bloomberg. -
Unsupervised, at-home methadone use appears safe, study suggests
Two years after the HHS cleared patients to take methadone, an opioid overdose treatment that's also an opioid, the number of opioid-related deaths didn't change, according to research from the National Institute on Drug Abuse and the CDC. -
Biden administration commits $1.5B for opioid epidemic
HHS is set to give about $1.5 billion to states and territories to battle the opioid epidemic. -
Overdose deaths up 15% in 2021, CDC data shows
Overdose deaths have reached a new high in the U.S., with the latest CDC data showing a 15 percent increase in fatalities last year.
Page 2 of 50